IN THE HIGH COURT OF JUDICATURE AT BOMBAY BENCH AT AURANGABAD
S.G. MEHARE, J.
Uday S/o Madhavrao Chandratre – Appellant
Versus
The State of Maharashtra – Respondent
Criminal Revision Application No. 445 of 2004
Decided on : 13-08-2024
Drugs - Manufacturing Offences - Drugs and Cosmetics Act, 1940 - Sections 33 EEC (a), 33 EEC (c), 33 I (1)(a)(ii), 33 I (1)(b) - The court upheld the conviction for manufacturing spurious drugs, emphasizing the significance of admissions and the procedural requirements under Section 313 of the Criminal Procedure Code.
Fact of the Case:
The applicant was charged with manufacturing spurious 'Gulvel Satva' under the Drugs and Cosmetics Act. Evidence included a letter of admission and a chemical analysis report confirming the product was substandard.
Finding of the Court:
The court found that the applicant's admission in Exhibit-28 was sufficient evidence of guilt, and the failure to question him under Section 313 did not vitiate the trial.
Issues: Whether the trial was vitiated by not allowing the applicant to explain the admission and whether the minimum sentence could be reduced under the Probation of Offenders Act.
Ratio Decidendi: The court held that an admission is strong evidence against the accused, and procedural lapses under Section 313 do not invalidate the conviction unless they cause prejudice.
Result: The applicant is released on probation instead of serving the minimum sentence.
JUDGMENT :
1. Heard learned counsel for the applicant and learned APP for the State.
2. The applicant/accused has impugned the judgment and order of the Chief Judicial Magistrate, Dhule in R.C.C. No.472/1994 dated 21.07.1999 as well as the order of the 2nd Additional Sessions Judge, Dhule in Criminal Appeal No.30/1999 dated 06.11.2004.
3. The applicant was charged for the offences punishable under Sections 33 EEC (a) and 33 EEC (c) punishable under Sections 33 I (1) (a)(ii) and 33 I (1) (b) of the Drugs and Cosmetics Act, 1940.
4. It was alleged against the applicant that the applicant was manufacturing spurious ‘Gulvel Satva’. He was running the pharmaceutical firm under the name M/s. Satpuda Pharmaceuticals. He had appointed the authorized agents for his product. The Drug Inspector visited one Madhura Agency and found the bottles containing medicine without any label, and other requisite details. When the inquiry was made, it was learnt that the applicant was manufacturing that medicine. The seized product was sent to the Chemical Analyzer. The Chemical Analyzer submitted the report that the substance was spurious and substandard. The applicant addressed a letter Exhibit-28 to the authority admitting that the seized medicine was manufactured in his company.
5. Both Courts, appreciating the evidence, believed that the seized medicine ‘Gulvel Satva’ was manufactured in the pharmaceutical company run by the applicant, namely M/s. Satpuda Pharmaceuticals. Holding the accused guilty, the learned Chief Judicial Magistrate sentenced him to suffer R.I. for one year and a fine of Rs.2000/- for the offence punishable under Section 33 I (1)(a) (ii) of the Drugs and Cosmetics Act and sentenced to suffer R.I. for three years and fine of Rs.5000/- for the offence punishable under Section 33 I (1)(b) of the Drugs and Cosmetics Act. The learned IInd Additional Sessions Judge, Dhule dismissed his appeal and maintained the conviction and sentence.
6. Learned counsel for the applicant has vehemently argued that the document Exhibit-28 was relied upon by the prosecution. However, no opportunity was granted to the applicant to explain it by way of a question to the accused under Section 313 of the Criminal Procedure Code. He vehemently argued that when the authorities visited the manufacturing unit, there was no stock or manufacturing process of the so-called ‘Gulvel Satva’. The medicine ‘Gulvel Satva’ was not spurious. He has pressed into service that since the material evidence/ circumstance was not brought to the notice of the applicant under Section 313 of the Criminal Procedure Code the entire trial was vitiated. In the alternative, he prayed that Section 33 of the Drugs and Cosmetics Act provides for passing the order less than one year for special reasons. He would argue that the Court, by way of adequate and special reasons, may impose a sentence of imprisonment for a term less than one year and a fine less than Rs.50,000/- or three times whatever is more. In alternative, he prayed for extending the benefit of the Probation of Offenders Act. To bolster his argument, he relied on a few case laws that would be referred in later part of the judgment.
7. Learned APP has strongly opposed the application. She would submit that the letter Exhibit-28 was never impugned. It was an admission letter of the applicant that the so-called product seized was manufactured in his factory. Since it was admitted to the accused, no such question was required to be asked to him under Section 313 of the Criminal Procedure Code. After seizing the manufacturing product from the medical shop, time was spent. So, probably in the meantime, the applicant might have stopped manufacturing ‘Gulvel Satwa’. There were no substantial grounds to warrant or interfere with the impugned judgment and order. There is no adequate or special reason to impose a penalty less than one year which was minimum punishment for the offence punishable under Section 33 EE (A) of the Drugs and Cosm
An admission of guilt can negate the need for further evidence, and procedural errors under Section 313 do not automatically invalidate a conviction.
Conviction under drug regulation provisions requires proving non-compliance, highlighting the importance of disclosing the manufacturer's details for legal protection.
At the stage of framing charges, the court should only consider the allegations made in the complaint and the supporting documents. The court should not delve into the evidence or conduct a mini-tria....
The conviction under the Drugs and Cosmetics Act requires proof of sale or stocking of drugs without a valid license, and procedural compliance in investigations is crucial for upholding such convict....
Directors are liable under the Drugs and Cosmetics Act for the conduct of the company's business, and summoning orders require only a prima facie case without extensive procedural scrutiny.
Non-compliance with inspection procedures under the Drugs and Cosmetics Act, 1940 is not fatal for prosecution in cases involving allegations of spurious drugs.
Possession of drugs without proper licensing constitutes a contravention of the Drugs and Cosmetics Act, justifying seizure and requiring trial for legality.
The expiry of a drug sample before testing negates the prosecution's case, impacting the accused's right to challenge the evidence.
Prosecution quashed for delay in sample testing beyond 60 days without extension under Rule 45 and failure to send sample to manufacturer under Section 23(4)(iii), depriving re-analysis right post sh....
Complaint for spurious drugs not quashable under CrPC 482 if allegations prima facie disclose offence; Magistrate takes cognizance of Chapter IV Drugs Act cases for committal to Sessions; manufacture....
Login now and unlock free premium legal research
Login to SupremeToday AI and access free legal analysis, AI highlights, and smart tools.
Login
now!
India’s Legal research and Law Firm App, Download now!
Copyright © 2023 Vikas Info Solution Pvt Ltd. All Rights Reserved.